Cdc20 and securin overexpression predict short-term breast cancer survival.
Karra H, Repo H, Ahonen I, Löyttyniemi E, Pitkänen R, Lintunen M, Kuopio T, Söderström M, Kronqvist P.
Karra H, et al. Among authors: lintunen m.
Br J Cancer. 2014 Jun 10;110(12):2905-13. doi: 10.1038/bjc.2014.252. Epub 2014 May 22.
Br J Cancer. 2014.
PMID: 24853182
Free PMC article.